Show simple item record

dc.contributor.authorKisely, Stephan
dc.contributor.authorCox, Martha
dc.contributor.authorCampbell, Leslie Anne
dc.contributor.authorCooke, Charmaine
dc.contributor.authorGardner, David
dc.date.accessioned2017-05-03T15:27:21Z
dc.date.available2017-05-03T15:27:21Z
dc.date.issued2009
dc.date.modified2010-09-13T07:10:35Z
dc.identifier.issn0706-7437
dc.identifier.urihttp://hdl.handle.net/10072/33922
dc.description.abstractObjective: Adverse effects from medication vary with age. Weight gain with several psychotropics is well known in adults but less information is available related to extent and complications of psychotropic-induced weight gain in older psychiatric patients. We determined the relative incidence of 2 obesity-related conditions (diabetes and hypertension) in older psychiatric patients receiving antipsychotics, antidepressants, and mood stabilizers. Method: A population-based case-control study of all psychiatric patients aged 67 years or older in contact with either specialist services or primary care using administrative data from Nova Scotia. Results: We identified incident cases of diabetes (n = 608) and of hypertension (n = 1056), as well as an equal number of control subjects for each condition. Amitryptiline, selective serotonin reuptake inhibitors (SSRIs), and olanzapine were associated with an increased risk of presenting with hypertension 6 months after initial prescription. By contrast, conventional antipsychotics were associated with a reduced incidence of hypertension. Olanzapine was also significantly associated with diabetes after 6 months (ORadj = 2.58, 95% CI 1.12 to 5.92). The findings for SSRIs and olanzapine remained significant after adjusting for potential confounders such as sociodemographic characteristics, schizophrenia, beta blockers, thiazide diuretics, and corticosteroids. Conclusions: Our results suggest that the association of psychotropics and 2 obesity-related conditions, hypertension and diabetes, applies to older psychiatric patients as well as younger populations. Within drug classes, there are drugs that have a greater association than others, and this may be a factor when choosing a specific agent.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.languageEnglish
dc.language.isoeng
dc.publisherCanadian Psychiatric Association
dc.publisher.placeCanada
dc.publisher.urihttp://publications.cpa-apc.org/media.php?mid=776
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom269
dc.relation.ispartofpageto274
dc.relation.ispartofissue4
dc.relation.ispartofjournalCanadian Journal of Psychiatry
dc.relation.ispartofvolume54
dc.rights.retentionY
dc.subject.fieldofresearchBiomedical and clinical sciences
dc.subject.fieldofresearchPsychology
dc.subject.fieldofresearchOther psychology not elsewhere classified
dc.subject.fieldofresearchcode32
dc.subject.fieldofresearchcode52
dc.subject.fieldofresearchcode529999
dc.titleAn Epidemiologic Study of Psychotropic Medication and Obesity-Related Chronic Illnesses in Older Psychiatric Patients
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.rights.copyright© 2009 Canadian Psychiatric Association. Self-archiving of the author-manuscript version is not yet supported by this publisher. Please refer to the journal link for access to the definitive, published version or contact the author for more information.
gro.date.issued2009
gro.hasfulltextNo Full Text
gro.griffith.authorKisely, Steve R.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record